Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Pseudomonas aeruginosa isolation is an important predictor for recurrent hemoptysis after bronchial artery embolization in patients with idiopathic bronchiectasis: a multicenter cohort study

Fig. 2

The cumulative hemoptysis control rate for all patients (n = 588). The median follow-up period of recurrence hemoptysis was 34.0 months (IQR, 24.3–53.3 months; range, 0.1–81.1 months). Hemoptysis occurred in 267 (45.4%) of 588 patients after BAE. The 1-month, 1-year, 2-year, and 5-year cumulative recurrence-free rates were 87.2%, 67.5%, 57.6%, and 49.4%, respectively. A total of 114 patients (19.4%) experienced recurrent severe hemoptysis, including 6 cases of pulmonary lobectomy and 9 cases of death. The 1-year, 2-year, and 5-year cumulative exacerbated hemoptysis-free rates were 91.4%, 84.9%, and 74.8%, respectively

Back to article page